FDA Patient Engagement Opportunities
On this Page:
GENERAL: PATIENT ENGAGEMENT OPPORTUNITIES
- Patient Listening Sessions
- Patient Engagement Collaborative (PEC)
- FDA Patient Representative Program
DRUG: PATIENT ENGAGEMENT OPPORTUNITIES
DEVICE: PATIENT ENGAGEMENT OPPORTUNITIES
GENERAL: PATIENT ENGAGEMENT OPPORTUNITIES
Patient Listening Sessions
Patient Listening Sessions are done in partnership with the National Organization for Rare Disorders (NORD). Patient Listening Sessions are a resource for the FDA medical product Centers to engage with patients or their advocates. Through Patient Listening Sessions patient communities can share their experience with a disease or condition by talking directly with FDA staff. Listening Sessions can either be FDA-requested (where FDA has a specific set of questions to ask) or patient-led (when a patient community wants to share their perspectives with the FDA).
Learn more about Patient Listening Sessions
Patient Engagement Collaborative (PEC)
The Patient Engagement Collaborative (PEC) is an FDA patient group established in collaboration with the Clinical Trials Transformation Initiative (CTTI). The PEC is composed of patient organization and individual representatives who discuss topics focusing on enhancing patient engagement in medical product development and regulatory discussions at FDA.
Learn More about Patient Engagement Collaborative (PEC)
FDA Patient Representative Program
The FDA Patient Representative Program® offers patients and caregivers the opportunity to provide critical advice to the agency as it regulates medical products—drugs, biologics, and devices. The role of the FDA Patient Representative® is unique. Patients and advocates are appointed as Special Government Employees (temporary employees) to provide direct input to agency staff as they share valuable insight on their experiences with various diseases, conditions, and devices while gaining access to confidential information.
Learn More about FDA Patient Representative Program
DRUG: PATIENT ENGAGEMENT OPPORTUNITIES
Patient-Focused Drug Development Initiative (PFDD)
Patient-Focused Drug Development (PFDD) is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation. As experts in what it is like to live with their condition, patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation.
Learn More about Patient Focused Drug Development Initiative
DEVICE: PATIENT ENGAGEMENT OPPORTUNITIES
Patient Engagement Advisory Committee (PEAC)
The Patient Engagement Advisory Committee (PEAC) is composed of patients, caregivers, and representatives of patient organizations. The FDA’s Center for Devices and Radiological Health (CDRH) established the PEAC to help assure that the needs and experiences of patients are included as part of the FDA’s discussions on complex issues involving the regulation of medical devices and their use by patients.
Learn More about Devices Patient Engagement Advisory Committee (PEAC)
Patient & Caregiver Connection (P&CC)
The Patient and Care-Partner Connection (P&CC) is a program with FDA’s Center for Devices and Radiological Health (CDRH). P&CC partners with patient organizations to provide a means for FDA staff to formally engage with patients and care-partners who share their individual experiences living with their disease or condition and/or their experiences with using medical devices for treatment, diagnosis, or assessment.